Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
Public ClinicalTrials.gov record NCT01003691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 1, DOUBLE-MASKED, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY, TOLERABILITY, IMMUNOGENICITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ESCALATING DOSAGES OF RN6G (PF-04382923) IN SUBJECTS WITH ADVANCED DRY, AGE-RELATED MACULAR DEGENERATION (AMD) INCLUDING GEOGRAPHIC ATROPHY
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and tolerability of multiple doses of RN6G in subjects with advanced dry, age-related macular degeneration including geographic atrophy.
Study identification
- NCT ID
- NCT01003691
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 5, 2010 (Actual)
- Primary completion
- Mar 5, 2013 (Actual)
- Completion
- Apr 19, 2013 (Actual)
- Last update posted
- May 12, 2022
2010 – 2013
United States locations
- U.S. sites
- 24
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Diagnostic Center | Campbell | California | 95008 | — |
| American Institute of Research (Administrative Only) | Los Gatos | California | 95032 | — |
| Neurology Center Rai Kumar | San Jose | California | 95116 | — |
| Harmeet Sachdev, MD, FAAN | San Jose | California | 95124 | — |
| Santa Clara Drug | San Jose | California | 95128 | — |
| Retina Associates of Florida, PA | Tampa | Florida | 33609 | — |
| Hoye's Pharmacy | Tampa | Florida | 33611 | — |
| Ranjit K. Sethi, MD, PC | Augusta | Georgia | 30901 | — |
| Clinical Specialists, LLC | Augusta | Georgia | 30907 | — |
| Southeast Retina Center, PC | Augusta | Georgia | 30909 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Hawthorne Pharmacy | West Columbia | South Carolina | 29169 | — |
| Jay Markowitz and Associates | West Columbia | South Carolina | 29169 | — |
| Palmetto Retina Center, LLC | West Columbia | South Carolina | 29169 | — |
| South Carolina Neurological | West Columbia | South Carolina | 29169 | — |
| National Central Pharmacy | Abilene | Texas | 79605 | — |
| Abilene Surgery Center | Abilene | Texas | 79606 | — |
| Heart and Vascular Institute | Abilene | Texas | 79606 | — |
| Retina Research Institute of Texas | Abilene | Texas | 79606 | — |
| Brian B. Berger, MD, PA | Austin | Texas | 78705 | — |
| Retina Research Center, PLLC | Austin | Texas | 78705 | — |
| Sleep Medicine Consultants | Austin | Texas | 78731 | — |
| Specialty Compounding | Cedar Park | Texas | 78613 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01003691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01003691 live on ClinicalTrials.gov.